Tailoring arthritis therapy in the wake of the NSAID crisis

N Engl J Med. 2005 Jun 23;352(25):2578-80. doi: 10.1056/NEJMp058105.
No abstract available

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Arthritis / drug therapy*
  • Celecoxib
  • Cyclooxygenase Inhibitors / adverse effects
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Humans
  • Lactones / adverse effects
  • Lactones / therapeutic use*
  • Pyrazoles / adverse effects
  • Pyrazoles / therapeutic use
  • Risk Assessment
  • Sulfonamides / adverse effects
  • Sulfonamides / therapeutic use
  • Sulfones / adverse effects
  • Sulfones / therapeutic use*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase Inhibitors
  • Lactones
  • Pyrazoles
  • Sulfonamides
  • Sulfones
  • rofecoxib
  • Celecoxib